You're right, it is huge. Not only does this partnership also make recruiting for clinical trials and penetrating the US market so much easier, but it also opens PAR up to potentially significant amounts of investment dollars from the US market. Similarly to how AFL players invested significantly in PAR a few years back, NFL players (and others) may also look to invest in PAR. Today's announcement further reinforces my view that PAR may look to list on the NASDAQ by the end of 2022.
My views only, not advice, DYOR
You're right, it is huge. Not only does this partnership also...
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $265.4K | 1.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 130186 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 11571 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |